Roivant Sciences Ltd (NASDAQ: ROIV) open the trading on Wednesday, with a bit cautious approach as it glided -4.34% to $11.02, before settling in for the price of $11.52 at the close. Taking a more long-term approach, ROIV posted a 52-week range of $9.69-$13.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 493.24% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 0.08%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -114.65%. This publicly-traded company’s shares outstanding now amounts to $733.33 million, simultaneously with a float of $376.90 million. The organization now has a market capitalization sitting at $8.02 billion. At the time of writing, stock’s 50-day Moving Average stood at $11.87, while the 200-day Moving Average is $11.37.
Roivant Sciences Ltd (ROIV) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Roivant Sciences Ltd’s current insider ownership accounts for 48.22%, in contrast to 67.68% institutional ownership. According to the most recent insider trade that took place on Dec 27 ’24, this organization’s President & COO sold 176,900 shares at the rate of 11.82, making the entire transaction reach 2,090,958 in total value, affecting insider ownership by 668,680. Preceding that transaction, on Dec 30 ’24, Company’s President & COO sold 177,704 for 11.54, making the whole transaction’s value amount to 2,050,704. This particular insider is now the holder of 740,976 in total.
Roivant Sciences Ltd (ROIV) Earnings and Revenue Records
Roivant Sciences Ltd’s EPS decrease for this current 12-month fiscal period is -114.65% and is forecasted to reach -1.09 in the upcoming year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Let’s observe the current performance indicators for Roivant Sciences Ltd (ROIV). It’s Quick Ratio in the last reported quarter now stands at 10.43. The Stock has managed to achieve an average true range (ATR) of 0.35. Alongside those numbers, its PE Ratio stands at $1.95, and its Beta score is 1.27. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 63.83.
In the same vein, ROIV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 5.66, a figure that is expected to reach -0.25 in the next quarter, and analysts are predicting that it will be -1.09 at the market close of one year from today.
Technical Analysis of Roivant Sciences Ltd (ROIV)
[Roivant Sciences Ltd, ROIV] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 12.47% While, its Average True Range was 0.36.
Raw Stochastic average of Roivant Sciences Ltd (ROIV) in the period of the previous 100 days is set at 1.45%, which indicates a major fall in contrast to 2.44% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 38.82% that was higher than 29.05% volatility it exhibited in the past 100-days period.
